Multicentric Castleman disease with cutaneous manifestations: Report of 2 cases and comparison with systemic plasmacytosis

Dermatology

Volumn 214, Issue 2, 2007, Pages 170-173

  Higashi, Yuko ^a   Kanekura, Takuro ^a   Sakamoto, Ryoko ^a   Mochitomi, Yuji ^a   Kanzaki, Tamotsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Lymphoma; Multicentric Castleman disease; Systemic plasmacytosis

Indexed keywords

CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABORATORY TEST; LYMPH NODE; LYMPHADENOPATHY; LYMPHOCYTE; MALE; PHYSICAL EXAMINATION; PLASMA CELL; PLASMACYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN INDURATION; T LYMPHOCYTE RECEPTOR GENE;

ADULT; BIOPSY; CELL PROLIFERATION; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; LYMPHATIC DISEASES; LYMPHOCYTES; MALE; MIDDLE AGED; PLASMA CELLS; SKIN; SKIN DISEASES;

EID: 33847699329     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098578     Document Type: Article

References (20)

1. Castleman B, Iverson L, Menendez VP: Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9:822-830.
2. Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-683.
3. Gaba AR, Stein RS, Sweet DL, Variakojis D: Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90.
4. McClain KL, Natkunam Y, Swerdlow SH: Atypical cellular disorders. Hematology Am Soc Hematol Educ Program 2004:283-296.
5. Frizzera G: Castleman's disease and related disorders. Semin Diagn Pathol 1988;5:346-364.
6. Kessler E: Multicentric giant lymph node hyperplasia: a report of seven cases. Cancer 1985;56:2446-2451.
7. Watanabe S, Ohara K, Kukita A, Mori S: Systemic plasmacytosis. Arch Dermatol 1986;122:1314-1320.
8. Kodama A, Tani M, Hori K, Tozuka T, Matsui T, Ito M, Nakao S, Fujita T, Kobayashi H: Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: significant serum interleukin-6 levels. Br J Dermatol 1992;127:49-53.
9. Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E: Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996;81:2976-2979.
10. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C: HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000;95:1406-1412.
11. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V: High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002;99:2331-2336.
12. Direkze S, Laman H: Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes. Int J Exp Pathol 2004;85:305-319.
13. Nitta Y: Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia. Am J Dermatopathol 1997;19:289-293.
14. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H: Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985;16:162-172.
15. Hafner C, Hohenleutner U, Babilas P, Landthaler M, Vogt T: Targeting T-cells to hit B-cells: successful treatment of cutaneous plasmacytosis with topical pimecrolimus. Dermatology 2006;213:163-165.
16. Shimizu S, Tanaka M, Shimizu H, Han-yaku H: Is cutaneous plasmacytosis a distinct clinical entity? J Am Acad Dermatol 1997;36:876-880.
17. Carey WP, Rico MJ, Nierodzik M, Sidhu G: Systemic plasmacytosis with cutaneous manifestations in a white man: successful therapy with cyclophosphamide/prednisone. J Am Acad Dermatol 1998;38:629-631.
18. Amin HM, McLaughlin P, Rutherford CJ, Abruzzo LV, Jones D: Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States. Am J Dermatopathol 2002;24:241-245.
19. Kimura K, Fujita H, Ishihama S: A case of cutaneous plasmacytosis (in Japanese). Hifu Rinsyo 1983;25:1045-1050.
20. Lopez-Estebaranz JL, Rodriguez-Peralto JL, Ortiz Romero PL, Vanaclocha F, Iglesias Diez L: Cutaneous plasmacytosis: report of a case in a white man. J Am Acad Dermatol 1994;31:897-900.